Advances in Sarcopenia: Predictive Biomarkers, Clinical Characteristics, and Therapeutic Strategies
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 34
Special Issue Editor
Interests: musculoskeletal diseases; electrodiagnostic medicine; spinal cord injury; intensive care unit rehabilitation; respiratory rehabilitation; sarcopenia
Special Issue Information
Dear Colleagues,
This Special Issue seeks to explore the advancements in the understanding, diagnosis, and treatment of sarcopenia, focusing on the integration of predictive biomarkers, clinical characteristics, and innovative therapeutic strategies. By compiling research on biochemical and physiological biomarkers, this Special Issue aims to determine the pathways through which the biomarkers of sarcopenia can be predicted and monitored more effectively. In addition to traditional clinical observations, we encourage submissions that utilize advanced imaging techniques, biometric analyses, and computational modeling to refine the clinical profiles associated with sarcopenia.
We also aim to highlight therapeutic advances, ranging from pharmacological interventions to non-invasive therapies that employ digital health technologies. The scope of this Special Issue extends to interdisciplinary approaches that combine nutrition and rehabilitation to offer comprehensive treatment. Through a collaborative exploration of these themes, this Special Issue will provide a platform for researchers to share insights and propose innovative solutions that address the global challenge of sarcopenia in aging populations. This Special Issue will serve as a crucial resource for clinicians and researchers involved in the management of sarcopenia.
Dr. Jong Geol Do
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sarcopenia
- predictive biomarkers
- digital health technologies
- interdisciplinary treatment approaches
- aging population management
